University Hospital Münster, Department of Neurology
Münster, 48149, Germany
Location status: Recruiting
NCT Number: NCT07606547
The aim of this non-randomized intervention study is to investigate the detailed effects of a structured four-week EMST® training program on the biomechanics of swallowing function in dysphagic Parkinson's patients. A combination of fiberoptic endoscopic evaluation of swallowing (FEES) and pharyngeal high-resolution manometry (HRM) will be employed to comprehensively evaluate the neuromuscular changes in swallowing.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Münster, 48149, Germany
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
5 sets of 5 breaths with EMST per day, 5 days a week for 1 month
Other names: EMST
Time frame: 1 month and 3 months
metrics of pharyngeal contraction and upper esophageal sphinkter opening in high-resolution pharyngeal manometry
Time frame: 1 month and 3 months
Assessment of Swallowing safety and efficiency with DIGEST-FEES (Dynamic Imaging Grade of Swallowing Toxicity - FEES), Range 0 (best) - 4 (worst)
Contact information is provided by the study sponsor or research team.
University Hospital Muenster
Other
Biomechanical Effects of Expiratory Muscle Strength Training (EMST®) on Swallowing Function in Parkinson's Disease - a Prospective High-resolution Manometry Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07734181
Basal Ganglia Diseases, Brain Diseases
Arlesheim, Basel-Landschaft, Switzerland
View Trial DetailsNCT07730073
Basal Ganglia Diseases, Brain Diseases
Kâğıthane, Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07630545
Basal Ganglia Diseases, Brain Diseases
Adelaide, Australia
View Trial DetailsNCT07284784
Basal Ganglia Diseases, Brain Diseases
Birmingham, Alabama, United States
View Trial Details